Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells
Age-related macular degeneration (AMD) is a leading cause of legal blindness in individuals over 60 years of age, characterized by the dysfunction of retinal pigmented epithelium cells, specifically in the macular area. Despite several treatment options, AMD therapy remains difficult, especially for...
Saved in:
Main Authors: | Raffaele Nuzzi, Monica Gunetti, Deborah Rustichelli, Barbara Roagna, Francesca Fronticelli Bardelli, Franca Fagioli, Ivana Ferrero |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2012/946090 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Mesenchymal Stem Cell-Derived Exosomes on Retinal Injury: A Review of Current Findings
by: Raffaele Nuzzi, et al.
Published: (2020-01-01) -
Anti-VEGF Treatment Strategies for Wet AMD
by: Jaclyn L. Kovach, et al.
Published: (2012-01-01) -
What Is New in Glaucoma: From Treatment to Biological Perspectives
by: Raffaele Nuzzi, et al.
Published: (2021-01-01) -
Systems Biology Profiling of AMD on the Basis of Gene Expression
by: Mones S. Abu-Asab, et al.
Published: (2013-01-01) -
Is There Any Point in a Corticosteroid Treatment of Intermittent Asthma?
by: Ivana Stankovic, et al.
Published: (2007-01-01)